8-K
false000153117700015311772022-06-082022-06-08

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 8, 2022

 

 

Sight Sciences, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-40587

80-0625749

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

4040 Campbell Avenue

Suite 100

 

Menlo Park, California

 

94025

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 877 266-1144

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.001 par value per share

 

SGHT

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 


 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On June 8, 2022, Sight Sciences, Inc. (the “Company”) held its annual meeting of stockholders. A total of 33,302,882 shares of the Company’s common stock were present in person or represented by proxy at the meeting, representing approximately 70.0% of the Company’s common stock outstanding as of the April 11, 2022 record date. Set out below are the voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 29, 2022.

 

Item 1 – Election of three Class I directors to serve until the Company’s annual meeting of stockholders to be held in 2025 and until their respective successors have been duly elected and qualified.

 

 

 

Votes FOR

 

 

Votes WITHHELD

 

 

Broker Non-Votes

 

Paul Badawi

 

 

29,040,248

 

 

 

2,414,236

 

 

 

1,848,398

 

Brenda Becker

 

 

31,405,336

 

 

 

49,148

 

 

 

1,848,398

 

Erica Rogers

 

 

27,239,339

 

 

 

4,215,145

 

 

 

1,848,398

 

 

Item 2 – Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.

 

Votes FOR

 

 

Votes AGAINST

 

 

Votes ABSTAINED

 

 

Broker Non-Votes

 

33,168,884

 

 

 

115,476

 

 

 

18,522

 

 

0

 

Based on the foregoing votes, Paul Badawi, Brenda Becker and Erica Rogers were elected as Class I directors, and the appointment of Deloitte & Touche LLP as the Company’s independent public accounting firm for the fiscal year ending December 31, 2022 was duly ratified.

 

 

 


 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Sight Sciences, Inc.

 

 

 

 

Date:

June 10, 2022

By:

/s/ Paul Badawi

 

 

 

President and Chief Executive Officer